Feedback / Questions
SY001 - CellOrigin Biotech
https://www.prnewswire.com/news-releases/cellorigin-announced-treatment-of-the-first-patient-with-car-m-in-china-and-reported-the-second-generation-of-car-m-for-solid-tumors-302020068.html
Dec 20, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev